Does A Private Sale Trigger The ‘On-Sale Bar’ For Patents?
From oral arguments in this case, it’s not clear how the Supreme Court will ultimately decide.
Muddy Waters? SCOTUS, Secret Sales, And The America Invents Act
How will SCOTUS address the issue? That is anything but certain.
Chrometa: Turning Time Into Billable Value For Modern Lawyers
Adoption of Chrometa represents more than a technological upgrade; it reflects a professional philosophy that values accuracy, transparency, and efficiency.
SCOTUS Upholds Constitutionality Of System To Challenge Bad Patents
Why should a government agency not be able to correct its own mistakes?
3 Observations From The Federal Circuit Judicial Conference
The Federal Circuit will continue in its efforts to bring uniformity to patent law, and will not shy away from challenges presented by the America Invents Act.
Why Assigning Patents To Native American Tribes To Avoid Inter Partes Review Is Bad Medicine
Here are three big reasons why, according to IP columnist Tom Kulik.
A New Patent Loophole? Paying Off A Native American Tribe To Exploit Its Sovereign Immunity
If this tactic is allowed, it will be a big win for Big Pharma -- and a big loss for patients and consumers.
Law Department Professionals: How Does Your Patent Management Stack Up?
Help us benchmark your organization with this survey and have a chance to win a $250 gift card.
Developing The Story Of Patent Litigation: Q&A With Cooley’s Ellen Scordino
This Biglaw partner brings pharma experience to law firm cases.
Is Patent Litigation Dead? What Gives?
Is the field of IP litigation still worth getting into?